GoodRx stockholders elect three Class II directors and ratify auditor at 2025 annual meeting

GoodRx Holdings, Inc.

Elected Christopher Adams, Trevor Bezdek, and Scott Wagner as Class II directors; each received >2.6B votes for.
Ratified PricewaterhouseCoopers as independent auditor for FY 2025; 99.9% voted for (2.66B for).
Advisory say-on-pay approved with 2.62B votes for (99.9% of votes cast excluding abstentions).
Total voting power at meeting represented ~99.5% of outstanding shares; Class B shares hold 10 votes each.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.